Upcycling technology company MacroCycle has accumulated $6.5 million in seed funding to commercialize its efforts to keep plastic waste out of landfills. The Cambridge, Massachusetts-based startup ...

The PPI was up 0.5% in September, which has higher than the 0.3% which had been projected by Dow Jones. But with that said, it was less than the 0.7% increase we saw in August, so at least the ...

MacroCycle Technologies, a developer of a novel polyethylene terephthalate (PET) and polyester textile scrap upcycling technology based in Cambridge, Massachusetts, has closed a $6.5 million seed ...

A team led by Novo Nordisk’s Rita Slaaby developed the glucose-responsive insulin, which is called NNC2215. The insulin in NNC2215 makes links to two moieties: a glucose-binding macrocycle and a ...

Macrocycle start-ups emerge from stealth 3 cyclic peptide–based firms announce funding in just over a week by Laura Howes February 29, 2024 ...

Circle Pharma’s First-in-Class Oral Macrocycle Cyclin A/B RxL Inhibitor, CID-078, Preclinical Data Highlighted at the 36th EORTC-NCI-AACR Symposium October 23, 2024 07:05 AM Eastern Daylight Time ...

Circle Pharma Presents Promising Preclinical Data on First-in-Class Oral Macrocycle Cyclin A/B RxL Inhibitor CID-078 at the San Antonio Breast Cancer Symposium 2024 December 09, 2024 10:05 AM ...

Well, macrocycle training — a more big-picture, year-long approach to fitness consisting of four phases that lead to a final goal, like a race or competition — could be the remedy for your ...

Protein-protein interfaces are stabilized by ‘hot spots’ of interactions; helices that drive some of these interactions have been used as inspiration for peptide inhibitors. A computational ...

Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing a new generation of macrocycle therapies, today announced a poster for preclinical data on CID-078 ...

Press Release Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing a new generation of macrocycle therapies, today announced that preclinical data from ...